1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hyperemia Global Clinical Trials Review, H2, 2014

Hyperemia Global Clinical Trials Review, H2, 2014

  • September 2014
  • -
  • Global Data
  • -
  • 53 pages

Hyperemia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Hyperemia Global Clinical Trials Review, H2, 2014" provides data on the Hyperemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hyperemia Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables3
List of Figures 4
Introduction 5
Hyperemia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Hyperemia to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Hyperemia Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Valeant Pharmaceuticals International, Inc. 24
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 24
Riemser Pharma GmbH 25
Clinical Trial Overview of Riemser Pharma GmbH 25
Dr. Reddy's Laboratories Limited 26
Clinical Trial Overview of Dr. Reddy's Laboratories Limited 26
Clinical Trial Overview of Top Institutes / Government 27
The University of Tokyo 27
Clinical Trial Overview of The University of Tokyo 27
University Hospital, Grenoble 28
Clinical Trial Overview of University Hospital, Grenoble 28
Institut Curie 29
Clinical Trial Overview of Institut Curie 29
Radboud University 30
Clinical Trial Overview of Radboud University 30
National Heart, Lung, and Blood Institute 31
Clinical Trial Overview of National Heart, Lung, and Blood Institute 31
Five Key Clinical Profiles 32
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Disclaimer 53
Source 53

List of Tables
Hyperemia Therapeutics, Global, Clinical Trials by Region, 2014* 6
Hyperemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hyperemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hyperemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Hyperemia Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Hyperemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Hyperemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Hyperemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Hyperemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Hyperemia Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Hyperemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Hyperemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Hyperemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Hyperemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Hyperemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 20
Hyperemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 21
Hyperemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 22
Hyperemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2014* 24
Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Riemser Pharma GmbH, 2014* 25
Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2014* 26
Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2014* 27
Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2014* 28
Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Curie, 2014* 29
Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2014* 30
Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 31

List of Figures
Hyperemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Hyperemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hyperemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hyperemia Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Proportion of Hyperemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Hyperemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Hyperemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Hyperemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Hyperemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
Hyperemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Hyperemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Hyperemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Hyperemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 20
Hyperemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 21
Hyperemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 22
Hyperemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
GlobalData Methodology 52

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.